Shared Mitochondrial Pathways Identified Across 23 Neurodevelopmental Risk Genes

The clinical landscape of neurodevelopmental disorders is defined by a frustrating paradox. While patients often present with overlapping symptoms such as impaired social communication and sensory processing, the underlying genetic drivers are remarkably diverse [1, 2]. Hundreds of rare variants in genes governing chromatin accessibility (the physical state of DNA that allows or restricts access for gene expression) and synaptic scaffolding have been implicated in conditions ranging from autism to severe intellectual disability [3, 4]. For instance, mutations in SHANK3, which encodes a scaffold protein at the post-synaptic density of glutamatergic synapses, are present in up to 2.12% of patients with moderate to profound intellectual disability [4]. This heterogeneity complicates diagnosis and leaves many patients without targeted therapeutic options, as most current treatments only address secondary symptoms rather than primary pathology [5, 6]. Understanding how these disparate genetic insults might converge on common biological pathways is essential for moving toward more effective, mechanism-based interventions [7]. A recent study now offers fresh insights into these molecular intersections by mapping the shared effects of dozens of risk genes across human neural cell types.